Azacitidine (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Azacitidine drug offered from Actavis Pharma, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Azacitidine
SUBSTANCE NAME: AZACITIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-09-22
END MARKETING DATE: 0000-00-00


Azacitidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAzacitidine from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2016-09-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-2897_ba887c6a-ff20-4683-b210-c673928060b8
PRODUCT NDC: 0591-2897
APPLICATION NUMBER: NDA208216

Other AZACITIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Azacitidine
BluePoint LaboratoriesAzacitidine
Breckenridge Pharmaceutical, Inc.Azacitidine
Celgene CorporationVIDAZA
Dr. Reddy’s Laboratories Inc.Azacitidine
Fresenius Kabi USA, LLCAzacitidine
Mylan Institutional LLCAzacitidine
Sandoz IncAzacitidine
Seton PharmaceuticalsAZACITIDINE
Shilpa Medicare LimitedAZACITIDINE
Wockhardt USA LLC.AZACITIDINE